FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135637406> ?p ?o ?g. }

• W2135637406 endingPage "600" @default.
• W2135637406 startingPage "588" @default.
• W2135637406 abstract "NXY-059 is a free-radical-trapping agent that is neuroprotective in animal models of stroke. We tested whether it would reduce disability in humans after acute ischemic stroke.We conducted a randomized, double-blind, placebo-controlled trial involving 1722 patients with acute ischemic stroke who were randomly assigned to receive a 72-hour infusion of placebo or intravenous NXY-059 within 6 hours after the onset of the stroke. The primary outcome was disability at 90 days, as measured according to scores on the modified Rankin scale for disability (range, 0 to 5, with 0 indicating no residual symptoms and 5 indicating bedbound, requiring constant care).Among the 1699 subjects included in the efficacy analysis, NXY-059 significantly improved the overall distribution of scores on the modified Rankin scale, as compared with placebo (P=0.038 by the Cochran-Mantel-Haenszel test). The common odds ratio for improvement across all categories of the scale was 1.20 (95 percent confidence interval, 1.01 to 1.42). Mortality and rates of serious and nonserious adverse events were each similar in the two groups. NXY-059 did not improve neurologic functioning as measured according to the National Institutes of Health Stroke Scale (NIHSS): the difference between the two groups in the change from baseline scores was 0.1 point (95 percent confidence interval, -1.4 to 1.1; P=0.86). Likewise, no improvement was observed according to the Barthel index (P=0.14). In a post hoc analysis of patients who also received alteplase, NXY-059 was associated with a lower incidence of any hemorrhagic transformation (P=0.001) and symptomatic intracranial hemorrhage (P=0.036).The administration of NXY-059 within six hours after the onset of acute ischemic stroke significantly improved the primary outcome (reduced disability at 90 days), but it did not significantly improve other outcome measures, including neurologic functioning as measured by the NIHSS score. Additional research is needed to confirm whether NXY-059 is beneficial in ischemic stroke. (ClinicalTrials.gov number, NCT00119626.)." @default.
• W2135637406 created "2016-06-24" @default.
• W2135637406 creator A5003407929 @default.
• W2135637406 creator A5026886390 @default.
• W2135637406 creator A5028934169 @default.
• W2135637406 creator A5033104412 @default.
• W2135637406 creator A5039358787 @default.
• W2135637406 creator A5041751659 @default.
• W2135637406 creator A5050507154 @default.
• W2135637406 creator A5064086551 @default.
• W2135637406 creator A5079574532 @default.
• W2135637406 creator A5086474167 @default.
• W2135637406 creator A5075196336 @default.
• W2135637406 date "2006-02-09" @default.
• W2135637406 modified "2023-10-16" @default.
• W2135637406 title "NXY-059 for Acute Ischemic Stroke" @default.
• W2135637406 cites W1513883393 @default.
• W2135637406 cites W1550111394 @default.
• W2135637406 cites W1848977294 @default.
• W2135637406 cites W1969661146 @default.
• W2135637406 cites W1972257422 @default.
• W2135637406 cites W1986468407 @default.
• W2135637406 cites W1995957050 @default.
• W2135637406 cites W2000366267 @default.
• W2135637406 cites W2032803467 @default.
• W2135637406 cites W2044546810 @default.
• W2135637406 cites W2049727876 @default.
• W2135637406 cites W205495280 @default.
• W2135637406 cites W2055946117 @default.
• W2135637406 cites W2068121825 @default.
• W2135637406 cites W2074463413 @default.
• W2135637406 cites W2078120261 @default.
• W2135637406 cites W2080279037 @default.
• W2135637406 cites W2080504768 @default.
• W2135637406 cites W2080850502 @default.
• W2135637406 cites W2105215015 @default.
• W2135637406 cites W2105534568 @default.
• W2135637406 cites W2112646710 @default.
• W2135637406 cites W2123636141 @default.
• W2135637406 cites W2144859488 @default.
• W2135637406 cites W2153878657 @default.
• W2135637406 cites W2172224520 @default.
• W2135637406 cites W2292308933 @default.
• W2135637406 cites W4238103798 @default.
• W2135637406 doi "https://doi.org/10.1056/nejmoa052980" @default.
• W2135637406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16467546" @default.
• W2135637406 hasPublicationYear "2006" @default.
• W2135637406 type Work @default.
• W2135637406 sameAs 2135637406 @default.
• W2135637406 citedByCount "609" @default.
• W2135637406 countsByYear W21356374062012 @default.
• W2135637406 countsByYear W21356374062013 @default.
• W2135637406 countsByYear W21356374062014 @default.
• W2135637406 countsByYear W21356374062015 @default.
• W2135637406 countsByYear W21356374062016 @default.
• W2135637406 countsByYear W21356374062017 @default.
• W2135637406 countsByYear W21356374062018 @default.
• W2135637406 countsByYear W21356374062019 @default.
• W2135637406 countsByYear W21356374062020 @default.
• W2135637406 countsByYear W21356374062021 @default.
• W2135637406 countsByYear W21356374062022 @default.
• W2135637406 countsByYear W21356374062023 @default.
• W2135637406 crossrefType "journal-article" @default.
• W2135637406 hasAuthorship W2135637406A5003407929 @default.
• W2135637406 hasAuthorship W2135637406A5026886390 @default.
• W2135637406 hasAuthorship W2135637406A5028934169 @default.
• W2135637406 hasAuthorship W2135637406A5033104412 @default.
• W2135637406 hasAuthorship W2135637406A5039358787 @default.
• W2135637406 hasAuthorship W2135637406A5041751659 @default.
• W2135637406 hasAuthorship W2135637406A5050507154 @default.
• W2135637406 hasAuthorship W2135637406A5064086551 @default.
• W2135637406 hasAuthorship W2135637406A5075196336 @default.
• W2135637406 hasAuthorship W2135637406A5079574532 @default.
• W2135637406 hasAuthorship W2135637406A5086474167 @default.
• W2135637406 hasBestOaLocation W21356374061 @default.
• W2135637406 hasConcept C126322002 @default.
• W2135637406 hasConcept C127413603 @default.
• W2135637406 hasConcept C142724271 @default.
• W2135637406 hasConcept C156957248 @default.
• W2135637406 hasConcept C164705383 @default.
• W2135637406 hasConcept C168563851 @default.
• W2135637406 hasConcept C1862650 @default.
• W2135637406 hasConcept C204787440 @default.
• W2135637406 hasConcept C27081682 @default.
• W2135637406 hasConcept C2780645631 @default.
• W2135637406 hasConcept C2780931571 @default.
• W2135637406 hasConcept C3020199598 @default.
• W2135637406 hasConcept C42219234 @default.
• W2135637406 hasConcept C44249647 @default.
• W2135637406 hasConcept C541997718 @default.
• W2135637406 hasConcept C67761136 @default.
• W2135637406 hasConcept C71924100 @default.
• W2135637406 hasConcept C78519656 @default.
• W2135637406 hasConceptScore W2135637406C126322002 @default.
• W2135637406 hasConceptScore W2135637406C127413603 @default.
• W2135637406 hasConceptScore W2135637406C142724271 @default.
• W2135637406 hasConceptScore W2135637406C156957248 @default.
• W2135637406 hasConceptScore W2135637406C164705383 @default.

• next